Scientists at King’s College London have developed an innovative IgE antibody therapy that activates the immune system to ...

Antibody treatment which activates the patient's own immune system against cancer, known as immunotherapy, is increasingly ...

Immunotherapy, or antibody treatment that activates the patient's own immune system against cancer, is increasingly being ...

Researchers at King's College London have developed IgE antibodies targeting HER2-expressing cancers. Early studies show ...

A study has established the importance of immunoglobulin A, an antibody that is part of the immune system, in generating a response to pneumonia vaccines. Researchers have found that the absence of ...

Michigan has confirmed its first measles case since last July. An Oakland County adult tested positive after recently ...

The FDA has granted fast-track designation to nipocalimab for the treatment of Sjögren’s disease, according to a press ...

Otsuka’s Taiho Pharmaceutical is paying $400 million upfront to acquire Switzerland’s Araris Biotech and its antibody-drug conjugate (ADC) linker platform.

A team of scientists is investigating a new type of antibody, which stimulates the immune system to target cancer cells and ...

Seismic Therapeutic, Inc., the machine learning immunology company, today announced the dosing of the first healthy subject ...

Batoclimab is an anti-FcRn treatment being developed for a range of autoimmune diseases and active thyroid eye disease (TED).

HER2 is responsible for cancer growth and is the target of existing therapies, such as the most commonly used type of antibodies, IgG. However, this treatment is not always effective in some patients.